Flyte LifeVac partnership sparks VTAK
Flyte LifeVac partnership sparks VTAK 54% premarket surge
- Flyte (VTAK subsidiary) to equip every Cirrus Vision Jet with LifeVac anti-choking devices
- July 7 announcement extends cabin safety with FDA-cleared airway clearance tool
- Builds on existing ecosystem: parachute, autoland, Garmin systems
- News released after July 7 close triggered AH gains then premarket momentum
- LifeVac credited with 6200+ global choking rescues
- Recent July 6 patents for VIVO mapping and heart failure tech add support
- Low-float nano-cap (~2M shares) amplifies retail-driven volatility
- Continues momentum from Flyte acquisition and aviation expansion strategy
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.